Purpose: Age-related macular degeneration (AMD) is a major cause of blindness in developed countries. Oxidative mechanisms may play a key role in the aetiology of AMD. The main aim of this study was to investigate antioxidative markers in the pathogenesis of AMD. Methods: A total of 510 subjects including 240 patients with AMD (mean age 77.9 AE 8.5 year) and 270 controls (mean age 74.0 AE 10.4 year) were allowed in this study. We measured activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and examined their association with the SNPs of respective genes (SOD1 + 35A/C, CAT C-262T and GPx Pro197Leu). Restriction fragment length polymorphism (RFLP) technique was used to determine the selected gene polymorphisms. Sixty subjects including 30 patients with AMD (mean age 69.4 AE 9.3) and 30 controls (mean age 64.6 AE 8.2) were enrolled to determine the activity of antioxidant enzymes by spectrometry method. Results: A significant decrease in enzymes, SOD (p = 0.011), CAT (p = 0.002) and GPx (p ≤ 0.001) in AMD patients compared to controls, was indicated. The risk of susceptibility to AMD was significantly higher in patients with AMD who had Pro197Leu C/T genotype of GPx (OR = 2.78; 95% CI = 1.78-4.35). The A/C genotype and the C allele frequencies of A/C polymorphism of SOD1 gene significantly reduce the risk of AMD (OR=0.48; 95% CI 0.27; 0.85). Conclusion: In conclusion, our data showed that insufficient antioxidant capacity may have an important role in age-related macular degeneration. The polymorphism of GPx Pro197Leu may reduce the ability to scavenge free radicals in retina and contribute to the development of AMD.
Introduction
Age-related macular degeneration (AMD) is a slow and progressive disease affecting the retinal cells in the macula, the region of the eye responsible for central vision. The literature shows that the world's 8.7% of the population is associated with age macular degeneration, and the number of cases will increase, about 196 million in 2020 and 288 million by the year 2040 (Wong et al. 2014 ).
Age-related macular degeneration (AMD) is a phenotypically heterogeneous disorder manifested by large drusen and pigmentary abnormalities in retinal pigment epithelium (RPE). Age-related macular degeneration (AMD) is generally divided into two forms: dry and wet that account for about 85% and 15% of cases, respectively. Dry AMD (geographic atrophy or non-exudative) referred to gradual deterioration of central vision as a result of atrophy of the RPE and photoreceptors of the macula. Wet form of AMD (neovascular or exudative form), associated with subretinal neovascularization which leads to the fibro-vascular scars and consequent loss of central vision, exhibits fast progression of disease (Kondo et al. 2009 ).
Age-related macular degeneration (AMD) risk factors are associated with genetic and environmental elements. Genomewide association studies (GWASs) have identified CFH on chromosome 1q32, LOC387715/ ARMS2 on 10q26, HTRA1 on 10q26 and C2/BF on 6p21, as major AMD susceptibility genes. Moreover, a disorder of the immune system -complement pathway activation -is considered to be the major pathological feature of AMD. Uncontrolled complement proteins promote reactions, including leucocyte accumulation, overproduction of free radicals and inefficient enzyme system, membrane attack complex (MAC)-induced RPE cell lysis and increase in vascular endothelial growth factor (VEGF), which leads to neovascularization (Horie-Inoue & Inoue 2014) . The most strongly associated environmental factors are age above 50 years, tobacco smoking and previous cataract surgery. Other risk factors may include female sex, white race, iris colour, high body mass index, history of cardiovascular disease, arterial hypertension and lifetime exposure to sunlight. Dietary factors, consumption of a non-balanced diet, high fat intake may be associated with increased AMD risk.
Therefore, retinal pigment epithelium cells become dysfunctional with age as a consequence of metabolic and phagocytic insufficiency. Their abnormality in the function leads to accumulation of lipofuscin -a biomarker of ageing. Oxidation of A2E (N-retinylidene-N-retinylethanolamine), photocytotoxic component of lipofuscin, can lead to harmful reactive oxygen species (ROS), which may damage the structure of proteins, lipids and DNA of RPE cells (Algvere et al. 2016) .
Reactive oxygen species seems to be the causative factor of oxidative damage of the cytoplasm and elements of nuclei of retinal cells. The retina is particularly susceptible to oxidative stress because of its high consumption of oxygen, its high proportion polyunsaturated fatty acids, and its exposure to high-energy visible light. Reactive oxygen species may damage lipids in the outer segments of photoreceptors and lead to progressive deterioration of the retinal pigment epithelium (RPE). Also, ROS modifies the compounds in the photoreceptors, which are then shed in the form of photoreceptor outer segments (POS) and phagocyted by RPE cells. Oxidatively damaged molecules, such as carboxyethylpyrrole, malondialdehyde, 4-hydroxynonenal, and advanced glycation end products, accumulate in the macular area and are a source for chronic oxidative stress (Kaarniranta et al. 2013) .
The retina contains a considerable number of antioxidants in the photoreceptor and RPE cells, mainly in the area of the macula. Antioxidant protection includes enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and non-enzymatic antioxidants as glutathione, albumin, uric acid, carotenoids and many others. It appears that antioxidant enzymes such as SOD, CAT and GPx play an important role in protecting the photoreceptors and RPE cells from oxidative damage.
The cure of a patient with AMD is unattainable at the present day. While there is little that can be done to improve the eyesight of someone who has AMD, with early detection, the rate of vision loss can be slowed. The AREDS2 study has shown that lutein, zeaxanthin, vitamin C, vitamin E, zinc, copper, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may reduce the impact of macular degeneration in some people by slowing its progression towards more advanced stages. Nutrients from the AREDS2 study set forth by the National Institutes of Health remain the most proven nutritional therapy for reducing the rate of advanced AMD (McCusker et al. 2016 ). However, therapeutic options for patients with the end-stage AMD are very restricted.
Taking into account these facts, we hypothesized that polymorphic variations in antioxidant genes may modify the risk of AMD. The aims of the current study were to examine the activity of SOD, GPx and CAT in red blood cells of AMD patients and controls and investigate their association with the SNPs of respective genes. Using the standard restriction fragment length polymorphism (RFLP) technique, we analysed three SNPs of antioxidant enzyme genes: SOD1 (rs2234694), CAT (rs1001179) and GPx (rs1050450).
Materials and Methods

Subjects
We examined the group of 510 individuals -240 AMD patients and 270 unrelated healthy controls who gave free consent to participate in the study. Control group comprised persons who were routinely examined in ophthalmology clinic, in whom AMD and other retinal diseases were excluded. Table 1 shows the demographic characteristics of the study participants.
Medical history was obtained from all subjects, and no one reported any genetic disease. The patients underwent ophthalmic examination, including best-corrected visual acuity, intra-ocular pressure, slit lamp examination and fundus examination, performed with a slit lamp equipped with either noncontact or contact fundus lenses. Diagnosis of AMD was confirmed by the use of optical coherence tomography (OCT) and, in some cases, by fluorescein angiography (FA) and indocyanine green angiography (ICG). Optical coherence tomography evaluated retinal thickness, the presence of RPE atrophy, drusen or subretinal fluid and intraretinal oedema; angiography assessed the anatomical status of the retinal vessels, the presence of choroidal neovascularization and leakage. Personal profile and clinical parameters of the patients are given in Table 2 .
The Bioethics Committee of the Warsaw Medical University, Poland, approved the study (KB/107/2008).
Blood samples and enzyme assays
We collected 4 ml of venous blood into EDTA tubes from all of the patients and the controls.
Erythrocytes were separated from blood plasma by centrifugation (10 min, 710 g) at 4°C and washed three times with 0.9% NaCl before examination. After the supernatant was removed, rinsed erythrocytes were haemolysed by adding redistillated water of each an equal quantity and then frozen at the temperature of À18°C to À20°C. The hemolysate, after being defrosted, was used in the subsequent studies.
Haemoglobin assay
Haemoglobin (Hb) concentration in erythrocyte hemolysate for the calculation of enzyme activities was estimated at 540 nm using a spectrometer (UV/ VIS Spectrometer Lambda 14P, Perkin Elmer, USA) after converting it into cyanmethemoglobin with Drabkin reagent (Aqua-Med, Poland) ( Van & Zijlstra 1961) .
Superoxide dismutase activity
Superoxide dismutase activity was measured according to procedure by Misra & Fridovich (1972) and expressed in adrenaline units (U/gHb/100 ml). The activity was determined at 37°C by the absorbance increase at 480 nm with a spectrometer (UV/VIS Spectrometer Lambda 14P, Bodenseewerk PerkinElmer GmbH, € Uberlingen, Germany) following by the auto-oxidation of epinephrine inhibited by SOD.
Catalase activity
Catalase activity was determined according to spectrophotometric procedure by Beers & Sizer (1952) and calculated as Bergmeyer units (BU/g Hb). This method is based on measured CAT activity at 25°C by recording H 2 O 2 decomposition at 240 nm with a spectrometer (UV/VIS Spectrometer Lambda 14P, PerkinElmer).
Glutathione peroxidase activity
Glutathione peroxidase activity in erythrocytes was assayed by the spectrophotometric procedure described by Little & O'Brien (1968) and presented as enzymatic units (U/g Hb). The difference in the rate of GPx reaction with glutathione and kumen in the sample was used for its activity determination by absorbance measurement with a spectrometer (UV/VIS Spectrometer Lambda 14P, PerkinElmer) at 412 nm.
DNA analysis
Genomic DNA was isolated from whole blood using Genomic Mini AX Blood (A&A Biotechnology, Gdynia, Poland) according to manufacturer's instructions.
SOD1, CAT and GPx genotypes were detected using PCR-RFLP method. Details are shown in Table 3 . Digested PCR products were visualized by UV transillumination after running on a 2% agarose gel and ethidium bromide staining compared against DNA ladder.
Statistical analysis
Probability values of less than 0.05 were considered as statistically significant. Genotype and allele frequencies for the SOD1, CAT and GPx polymorphisms were calculated from observed genotype counts. These frequencies were assessed for association with NP using the standard chi-square test or Fisher's exact test. Hardy-Weinberg equilibrium test was performed for both study groups. Odds ratio (OR) and corresponding 95% confidence intervals (CI) were used to assess correlations between genotypes and alleles and AMD.
The Mann-Whitney U-test was used to correlate between the levels of antioxidant enzyme activities and enzyme genotypes in the patients with AMD.
Results
A total of 510 subjects were enrolled in this study: 240 patients in AMD group and 270 in control group. The AMD group including 150 women (average age 79.2 AE 8.5 years) and 90 men (average age 80.5 AE 8.2 years), while in the control group, there were 178 women (average age 74.6 AE 10.2 years) and 92 men (average age 73.1 AE 11.0 years).
Tables 4-6 presented the distribution of genotype frequencies of SOD1 + 35A/ C (Table 4) , CAT C-262T (Table 5) and GPx Pro197Leu (Table 6 ) polymorphisms in AMD patients and healthy subjects.
The analysis of the SOD1 + 35A/C polymorphism located adjacent to the splice site (exon 3/intron 3 boundary) showed that 215 were wild type for the A/A genotype, 1 was variant homozygous for the C/C genotype, and 24 were heterozygous for the A/C genotype.
Distribution of the genotypes in the AMD group and controls was in agreement with HWE (p = 0. 17; v 2 = 0.14 and p = 0.51; v 2 = 0.42, respectively). The A/C genotype and the C allele frequencies of A/C polymorphism of SOD1 gene reduced the risk of AMD (OR = 0.48; 95% CI 0.27; 0.85). The allele and genotype frequencies of the C-262T in the promoter region of the catalase gene of the control group and AMD patients are presented in Table 5 . No statistically significant differences were found between AMD patients and the control group with regard to genotype distribution and allele frequencies of C-262T polymorphism of CAT gene. Mean SOD1 and CAT activities in erythrocytes did not differ significantly in the AMD group with the SOD1 + 35A/C and CAT C-262T polymorphisms.
Glutathione peroxidase is located on 3p21.3 and has a polymorphism on the position 593 resulting in the substitution of proline to leucine. Statistically significant differences in the genotype distribution between the study groups were shown in Table 6 . The risk to the development of age-related macular degeneration was significantly higher in patients with AMD who had Pro197Leu C/T genotype of GPx (OR = 2.78; 95% CI = 1.78-4.35) and T/T genotype of GPx (OR = 1.94; 95% CI 1. 05-3.56) than in the control group. The allele frequency of the T allele of GPx Pro197Leu was significantly different in the AMD group (p = 0.014, OR = 1. 36; 95% CI = 1.07-1.75) when compared to the control group. Analysis revealed that there were statistically significant differences between GPx activity and GPx genotype in the AMD objects with the Pro197Leu C/C genotype than those with the Pro197Leu C/T (28.8 U/gHb versus 34.58 U/gHb).
Results of antioxidant enzyme activities are presented in Table 7 . Thirty patients with AMD, 11 men and 19 women, mean age of 69.4 AE 9.3 years were enrolled in this study. The control group consisted of thirty subjects, nine men and 21 women, mean age 64.6 AE 8.2 years without AMD symptoms.
The SOD (U/gHb/100 ml) activity was significantly lower in the examined group of patients with AMD compared to controls (2068.2 AE 139.1 versus 2327.9 AE 525.3; p = 0.011). The statistically significant decrease in CAT (BU/gHb) activity was observed in erythrocyte of AMD cases relative to controls (6.8 AE 0.7 versus 7.6 AE 1.1; p = 0.002). The activity of GPx (U/ gHb) was significantly decreased in AMD patients compared to healthy subject (35.4 AE 8.7 versus 45.3 AE 10.5; p ≤ 0.001).
The antioxidant enzyme activities depending on genotypes in patients with AMD are showed in Table 8 .
Discussion
The retina is exposed to a constant source of oxidative stress from exposure to light, leading to photo-oxidation, which in turn generates reactive oxygen species (ROS) within the retina. The imbalance between the production and neutralization of free radicals by antioxidant system may contribute to the initiation and progression of AMD. Overproduction of ROS may lead to the mtDNA damage, caspase/cytochrome C release, protein modification, increase inflammation and produce cellular damage in the retina (Khandhadia & Lotery 2010) .
Furthermore, oxidative stress promotes lipofuscin accumulation in the RPE cells. Reactive oxygen species production is dependent on the visible wavelength of light because highest levels of ROS were generated when lipofuscin was exposed to blue light. Lipofuscin shows a typical autofluorescence from its yellow-brownish pigment granules and lipid containing residues of lysosomal digestion. It is a product of the oxidation of unsaturated fatty acids and responsible for damage to mitochondria and lysosomes during ageing.
Lipofuscin increases production of ROS including superoxide anion, singlet oxygen, hydrogen peroxide and lipid peroxides (Funk Richard et al. 2014) .
Subsequent processes contributing to the development of the disease are drusogenesis, inflammation and neovascularization (in wet type AMD). Drusen-insoluble deposits mechanical damage RPE cells leading to local inflammation. Furthermore, they interfere with the transport of nutrients and oxygen from Bruch's membrane to the photoreceptors, causing on the one (Nowak & Bienias 2007; McHarg et al. 2015) .
Because the retina is highly susceptible to oxidative damage, it has developed a range of protective mechanisms. Antioxidant enzymes like superoxide dismutase, catalase and glutathione peroxidase are a key molecules that protects the retina from reactive oxygen species and those enzymes are found in the photoreceptors and in the retinal pigment epithelium (RPE).
Copper-zinc superoxide dismutase 1 enzyme (CuZnSOD or SOD1) plays a crucial role in the detoxification of superoxide anions and protects cells from free radical-induced oxidative damage. This enzyme catalyses the one-electron dismutation of superoxide anion. Catalase (CAT) is second key antioxidant enzyme which scavenges hydrogen peroxide. Glutathione peroxidase (GPx), an enzyme dependent on the micronutrient selenium (Se), plays a critical role in the reduction of an organic and inorganic hydroperoxides. If GPx activity is decreased, more hydrogen peroxide is present, which leads to tissue damage and activation of nuclear factor-jBrelated inflammatory pathways (Espinoza et al. 2008) .
Every modification in antioxidant genes such as SOD, CAT, GPx causes changes in enzyme activity, quantity and protection from free radicals.
Our study describes the association between SOD1 + 35A/C, CAT C-262T and GPx Pro197Leu polymorphisms with the risk of age-related macular degeneration in the Polish population because these polymorphisms may change the enzymes' antioxidant capacity.
The human SOD1 gene which located on chromosome 21q22.11 is highly polymorphic and has ethnic specificity. In SOD1, the +35A/C polymorphism is adjacent to the splicing point (exon 3/intron 3), being related to the SOD1 activity. This gene represents about 50-80% of the total SOD activity and is an important defence system against overproduction free radicals (Faraci & Didion 2004 ). In our experiments, we found that SOD1 + 35A/C polymorphism, the A/C genotype and the C allele frequencies were associated with protection against AMD in a Polish population (OR = 0.48; 95% CI 0.27; 0.85).
Catalase, another component of antioxidant system, reacts with hydrogen peroxide and converts it to water and molecular oxygen. The catalase CAT gene is located on chromosome 11p13 and contains 13 exons. Catalase activity is probably to be affected by functional polymorphism of C-262T in the CAT gene. This polymorphism in the promoter region of the CAT gene was found to be related with changed CAT activity (Nadif et al. 2005) . Low CAT activity with the reduced expressing forms of the CAT C-262T polymorphism may lead to oxidative damage in retina or/and macula, and it increases susceptibility to the AMD risk. Our data analysis showed no significant association with risk of AMD and the CAT gene promoter polymorphism C-262T in Poland.
Selenium-dependent glutathione peroxidase (GPx), another enzyme that protects of cells from oxidative stress, is encoded by GPx1 gene, which is located on chromosome 3p21 and contains two exons. This gene contains polymorphism of the cytosine-to-thymine (C>T) substitution at codons 198 and 197, resulting in Pro198Leu and Pro197Leu variations.
Our study revealed that the polymorphism of GPx Pro197Leu reduces the antioxidant capacity and this gene polymorphism is risk factor for increased susceptibility to age-related macular degeneration. The results presented significant association between GPx Pro197Leu and the risk of AMD and Pro197Leu C/T and T/T genotypes and T allele frequency.
In our study, the significant decreased activity of primary antioxidant enzymes such as superoxide dismutase (11%), catalase (12%) and glutathione peroxidase (22%) in erythrocytes of AMD patients comparing to healthy control has been demonstrated. The highest decrease in GPx activity was found which is suggested to play a key role in antioxidant protection because of its high relationship to hydrogen peroxide. The patients with AMD in our study displayed enhanced sensitivity to hydrogen peroxide treatment compared to controls as estimated by the level of enzyme activity depending on selected genotypes, either. Statistical analysis showed significant correlation between GPx activities (U/gHb) in GPx Pro197-Leu C/C versus C/T genotypes in the AMD objects. In the literature, the association between the CAT, SOD1 and GPx gene polymorphism and other agerelated diseases such as breast cancer (Saadat & Saadat 2015) , type 2 diabetes (Vats et al. 2015) , prostate (Arsova-Sarafinovska et al. 2009 ), Alzheimer (Crawford et al. 2012) , cataract (Yi et al. 2011 ) has been reported.
In the available bibliography are little studies on the relationship between an SOD1 polymorphism and age-related macular degeneration. Many studies have implicated SOD2 polymorphisms as potential determinants of disease susceptibility, there are no reports on the association between the +35A/C promoter polymorphism of the SOD1 gene and AMD.
The SOD2 associated with manganese is an intramitochondrial antioxidant enzyme that protects against superoxide produced as a by-product of oxidative phosphorylation. Previous studies in the literature have examined the association between genes encoding antioxidant enzymes as risk factors for the development of AMD, with varying results.
An association with a polymorphism in the SOD2 gene with AMD was found in a Japanese population (Kimura et al. 2000) , but Kondo et al. (2009) found no detectable association of the SOD2 with AMD in a Japanese population. Similarly, no significant association with AMD was observed in a Northern Irish population (Esfandiary et al. 2005) .
A study carried out in Japan on AMD population (but SOD2 polymorphism) (Gotoh et al. 2008 ) agreed with our results, and it has been reported that polymorphisms in SOD1 and SOD2 genes were protected against age-related macular degeneration.
In the literature, researchers reported that the Leu/Leu genotype was correlated with reduction in GPx activity and increased susceptibility of disease (Hansen et al. 2009; Hu et al. 2010; Kucukgergin et al. 2011) . Therefore, it is presumed that GPx Pro197Leu polymorphism affected on GPx1 activity and may be important for AMD development.
In contrast, Saghar (2014) have reported that the C/T+T/T genotype at position -262 of CAT was associated with protection against AMD in Iranian patients if compared with C/C genotype.
Several experimental studies showed that levels of antioxidant enzyme activity in erythrocytes were lower in AMD group than healthy subjects. Low superoxide dismutase, glutathione reductase and glutathione peroxidase (Evereklioglu et al. 2003; Zafrilla et al. 2013) , TTS (total thiol status), PON1 (paraoxonase) and high-level TOS (total oxidant status) (U gurlu et al. 2013) and concentration of plasma malondialdehyde (MDA; Evereklioglu et al. 2003) were indicated. Plestina-Borjan et al. (2015) reported that the activity of SOD, CAT, GPx in erythrocytes and serum TAS (total antioxidant status) in agerelated macular degeneration patients was lower than control group. Moreover, the study showed that low GPx activity and TAS are associated with AMD. Yildirim et al. (2004) revealed lower CAT activity and elevated plasma MDA level in AMD patients than controls. Malondialdehyde is a marker that determines the extent of lipid peroxidation and serves as an indicator of cellular damage caused by free radicals in patients with disease, including AMD. The results suggested that retina is susceptible to lipid peroxidation, and this susceptibility also increases with ageing in the macular region.
In contrast, in literature, researchers presented the results of increased activity of antioxidant enzymes. Our observation is not supported by all investigators, because Jia et al. (2011) and Shen et al. (2012) found an increase in SOD activity in AMD patients. The authors explained the higher activity of enzymatic antioxidant defence and high concentration of plasma MDA as a compensatory regulation in response to oxidative damage in patients with AMD.
In this study, the statistically significant decrease in activity of antioxidant enzymes may link with oxidative damage, overproduce reactive nitrogen and oxygen species, inflammation, errors in protein synthesis which may contribute to catalytically less active enzymes or proteins more susceptible to proteolytic degradation in patients with AMD. However, please note that the AMD is a disease after 50 years of age and with increasing age, antioxidant levels loss and reactive oxygen species elevated in most tissues, and this associated with a number of diseases, including AMD. The abnormalities of the pro-oxidant/ antioxidant status can lead to oxidative damage, especially when the enzymatic protection status weakens in elderly. These findings implicate that ROS plays an essential role during the progression of AMD. Moreover, we suggest that the obtained data might reflect considerable impairment of antioxidant defence system in AMD patients.
Conclusion
In summary, present data supported the hypothesis that patients with AMD may possess impaired antioxidant defence system resulting in reduced of antioxidant enzyme activities. There are multiple environmental and genetic factors are involved in the development of AMD and which may influence the association between the clinical manifestation of the disease and polymorphism in one or more antioxidant enzyme genotypes. This report is one of the few that assumes the relationship between polymorphisms of genes of antioxidant enzymes with AMD in the Polish population. In our experiments, we found that SOD1 + 35A/C polymorphism was associated with protection against AMD. It seems necessary to compare our research selected polymorphisms with other ethnic groups and nationalities. The polymorphism of GPx Pro197Leu may diminish the ability to scavenge hydrogen peroxide in retina, overproduce reactive oxygen species and contribute to the development of age-related macular degeneration.
